Image For Activity Cover
Expert Monitoring for Safe Opioid Prescribing
Mary Milano Carter, MS, ANP-BC, RN-BC, Nurse Practitioner, Chronic Pain Service, North Shore University Hospital/ Northwell Health; Terry Grimes, PhDc, FNP-BC, RN-BC, CCRN, Nurse Practitioner, Integrative Pain NP, Mather Hospital Northwell Health
Target Audience
Prescribers and clinicians such as Advanced Practice nurses, Registered Nurses, Physician Assistants who work with clients who are prescribed opiates in the work setting.
Webinar Description
Attendees will gain a clearer understanding of the treatment of the patient in pain within today’s environment of opioid epidemic. Content regarding drug toxicology methods and results are detailed through factual information and followed with case studies to reinforce clinical application. The content is especially valuable in today’s need to balance opioid misuse and overdose with appropriate pain management.
The presentation will review the latest federal and examples of state guidelines for providing pain management in the current environment of opioid misuse and overdose with best practices to initiate and continue a plan of treatment.
Educational Objectives

At the conclusion of this activity, learners should be able to:

  1. Differentiate between various drug testing methodologies
  2. Through a case study format, learn the intricacies of interpreting complex toxicology testing results
  3. Provide guidelines of expert monitoring for safe opioid prescribing
Availability: On-Demand
Expires on 07/14/2023
Cost: FREE
Credit Offered:
1 Attendance Credit
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.

Funding for this initiative was made possible (in part) by grant nos. 6H79TI081968 and 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

For Buprenorphine Training Inquiries, email PCSS.


Powered By